Crystal structure, antitumour and antimetastatic activities of disubstituted fused 1,2,4-triazinones
作者:Krzysztof Sztanke、Kazimierz Pasternak、Małgorzata Sztanke、Martyna Kandefer-Szerszeń、Anna E. Kozioł、Izabela Dybała
DOI:10.1016/j.bmcl.2009.07.036
日期:2009.9
4]triazin-4(6H)-ones (8–14) was confirmed by X-ray crystallography of 14. All the compounds were evaluated for their antitumour and antimetastatic activities in vitro. Furthermore, their cytotoxicities towards human normal cell line—HSF cells were established, allowing us to point out some structure–activity relationships. Among them, imidazotriazinone 12, revealing remarkable dose-dependent viability decreases in human
的分子结构3,8-二取代的-7,8-二氢咪唑并[2,1- c ^ ] [1,2,4]三嗪-4(6 ħ) -酮(8 - 14)通过的X射线晶体学确认14。评估了所有化合物的体外抗肿瘤和抗转移活性。此外,还建立了它们对人类正常细胞系HSF细胞的细胞毒性,这使我们指出了一些结构与活性之间的关系。其中,咪唑三嗪酮12在人骨髓瘤RPMI 8226细胞中显示出显着的剂量依赖性生存力降低,被发现对正常HSF细胞完全无毒。此外,杂环自行车8 – 12 被证明在动力试验中显示出显着的抗转移潜力。